Estimating the effectiveness of routine asymptomatic PCR testing at different frequencies for the detection of SARS-CoV-2 infections
- PMID: 33902581
- PMCID: PMC8075718
- DOI: 10.1186/s12916-021-01982-x
Estimating the effectiveness of routine asymptomatic PCR testing at different frequencies for the detection of SARS-CoV-2 infections
Abstract
Background: Routine asymptomatic testing using RT-PCR of people who interact with vulnerable populations, such as medical staff in hospitals or care workers in care homes, has been employed to help prevent outbreaks among vulnerable populations. Although the peak sensitivity of RT-PCR can be high, the probability of detecting an infection will vary throughout the course of an infection. The effectiveness of routine asymptomatic testing will therefore depend on testing frequency and how PCR detection varies over time.
Methods: We fitted a Bayesian statistical model to a dataset of twice weekly PCR tests of UK healthcare workers performed by self-administered nasopharyngeal swab, regardless of symptoms. We jointly estimated times of infection and the probability of a positive PCR test over time following infection; we then compared asymptomatic testing strategies by calculating the probability that a symptomatic infection is detected before symptom onset and the probability that an asymptomatic infection is detected within 7 days of infection.
Results: We estimated that the probability that the PCR test detected infection peaked at 77% (54-88%) 4 days after infection, decreasing to 50% (38-65%) by 10 days after infection. Our results suggest a substantially higher probability of detecting infections 1-3 days after infection than previously published estimates. We estimated that testing every other day would detect 57% (33-76%) of symptomatic cases prior to onset and 94% (75-99%) of asymptomatic cases within 7 days if test results were returned within a day.
Conclusions: Our results suggest that routine asymptomatic testing can enable detection of a high proportion of infected individuals early in their infection, provided that the testing is frequent and the time from testing to notification of results is sufficiently fast.
Keywords: COVID-19; Healthcare workers; PCR testing; Presymptomatic infections; SARS-CoV-2; Test sensitivity.
Conflict of interest statement
The authors declare that we have no competing interests.
Figures
Similar articles
-
Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.Cochrane Database Syst Rev. 2021 Mar 24;3(3):CD013705. doi: 10.1002/14651858.CD013705.pub2. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 Jul 22;7:CD013705. doi: 10.1002/14651858.CD013705.pub3. PMID: 33760236 Free PMC article. Updated.
-
Universal screening for SARS-CoV-2 infection: a rapid review.Cochrane Database Syst Rev. 2020 Sep 15;9(9):CD013718. doi: 10.1002/14651858.CD013718. Cochrane Database Syst Rev. 2020. PMID: 33502003 Free PMC article.
-
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3. Cochrane Database Syst Rev. 2022. PMID: 35866452 Free PMC article. Review.
-
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z. Trials. 2021. PMID: 33419461 Free PMC article.
-
Antibody tests for identification of current and past infection with SARS-CoV-2.Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2. Cochrane Database Syst Rev. 2022. PMID: 36394900 Free PMC article. Review.
Cited by
-
Combined analyses of within-host SARS-CoV-2 viral kinetics and information on past exposures to the virus in a human cohort identifies intrinsic differences of Omicron and Delta variants.PLoS Biol. 2024 Jan 30;22(1):e3002463. doi: 10.1371/journal.pbio.3002463. eCollection 2024 Jan. PLoS Biol. 2024. PMID: 38289907 Free PMC article.
-
Reconstructing the COVID-19 incidence in India using airport screening data in Japan.BMC Infect Dis. 2024 Jan 2;24(1):12. doi: 10.1186/s12879-023-08882-w. BMC Infect Dis. 2024. PMID: 38166666 Free PMC article.
-
The impact of SARS-CoV-2 on healthcare workers of a large University Hospital in the Veneto Region: risk of infection and clinical presentation in relation to different pandemic phases and some relevant determinants.Front Public Health. 2023 Nov 30;11:1250911. doi: 10.3389/fpubh.2023.1250911. eCollection 2023. Front Public Health. 2023. PMID: 38098828 Free PMC article.
-
Inactivated SARS-CoV-2 Vaccine Booster Against Omicron Infection Among Quarantined Close Contacts.JAMA Netw Open. 2023 Oct 2;6(10):e2339507. doi: 10.1001/jamanetworkopen.2023.39507. JAMA Netw Open. 2023. PMID: 37878315 Free PMC article.
-
Rapid prototyping of models for COVID-19 outbreak detection in workplaces.BMC Infect Dis. 2023 Oct 23;23(1):713. doi: 10.1186/s12879-023-08713-y. BMC Infect Dis. 2023. PMID: 37872480 Free PMC article.
References
-
- Vivaldi 1: COVID-19 care homes study report. GOV.UK. Available from: https://www.gov.uk/government/publications/vivaldi-1-coronavirus-covid-1.... [cited 2020 Nov 10]
-
- Rickman HM, Rampling T, Shaw K, Martinez-Garcia G, Hail L, Coen P, et al. Nosocomial transmission of coronavirus disease 2019: a retrospective study of 66 hospital-acquired cases in a London teaching hospital. Clin Infect Dis; Available from: https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa816/586.... [cited 2020 Nov 10] - DOI - PMC - PubMed
-
- Verity R, Okell LC, Dorigatti I, Winskill P, Whittaker C, Imai N, Cuomo-Dannenburg G, Thompson H, Walker PGT, Fu H, Dighe A, Griffin JT, Baguelin M, Bhatia S, Boonyasiri A, Cori A, Cucunubá Z, FitzJohn R, Gaythorpe K, Green W, Hamlet A, Hinsley W, Laydon D, Nedjati-Gilani G, Riley S, van Elsland S, Volz E, Wang H, Wang Y, Xi X, Donnelly CA, Ghani AC, Ferguson NM. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. 2020;20(6):669–677. doi: 10.1016/S1473-3099(20)30243-7. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
- 206471/Z/17/Z/WT_/Wellcome Trust/United Kingdom
- 206250/Z/17/Z/WT_/Wellcome Trust/United Kingdom
- MC_PC_19065/MRC_/Medical Research Council/United Kingdom
- MR/T001127/1/MRC_/Medical Research Council/United Kingdom
- 10758/Z/18/Z/WT_/Wellcome Trust/United Kingdom
- 21999/CRUK_/Cancer Research UK/United Kingdom
- MC_U117597139/MRC_/Medical Research Council/United Kingdom
- WT_/Wellcome Trust/United Kingdom
- 17786/CRUK_/Cancer Research UK/United Kingdom
- MC_PC_19082/MRC_/Medical Research Council/United Kingdom
- 208812/Z/17/Z/WT_/Wellcome Trust/United Kingdom
- MC_U117562207/MRC_/Medical Research Council/United Kingdom
- 30025/CRUK_/Cancer Research UK/United Kingdom
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous